Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.
Bevacizumab treatment can result in tumor shrinkage of progressive vestibular schwannomas in some neurofibromatosis 2 (NF2) patients but its effect on meningiomas has not been defined. To determine the clinical activity of bevacizumab against NF2-related meningiomas, we measured changes in volume of...
Guardado en:
Autores principales: | Fabio P Nunes, Vanessa L Merker, Dominique Jennings, Paul A Caruso, Emmanuelle di Tomaso, Alona Muzikansky, Fred G Barker, Anat Stemmer-Rachamimov, Scott R Plotkin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f1f7da0af9c04824ac2ec64c9d11a7a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic landscape of high-grade meningiomas
por: Wenya Linda Bi, et al.
Publicado: (2017) -
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
por: Long-Sheng Chang, et al.
Publicado: (2021) -
Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas
por: Sameer Agnihotri, et al.
Publicado: (2017) -
Isolated Intraconal Meningioma
por: Mohammad Taher Rajabi, et al.
Publicado: (2021) -
Intraosseous meningioma mimicking osteosarcoma
por: Ruben Delgado, et al.
Publicado: (2021)